Abstract

Research Article

High water intake in preventing the risk of Uric Acid Nephrolithiasis: A systematic review and meta-analysis

Zhijian Lin, John C Lieske, Yue Li and Muthuvel Jayachandran*

Published: 12 July, 2019 | Volume 3 - Issue 2 | Pages: 126-142

Background: Hyperuricosuria, persistently low urinary pH, and low urinary volume are the main risk factors of uric acid nephrolithiasis. Epidemiologic studies suggest that high water intake is protective against the occurrence of symptomatic kidney stone events of all types. The objective of this systematic review and meta-analysis were to evaluate the effectiveness of increased water intake to prevent symptomatic uric acid kidney stone events.

Methods: Seventeen studies were identified for the meta-analysis. Analysis of Q and I2% statistics revealed that a high heterogeneity in 16 studies, thus, random effects model was used. Protective associations were identified for high water intake individuals (SMD=0.52 L; 95% CI: 0.19, 0.84; p=0.002); a significantly decreased relative super saturation of uric acid versus controls (SMD=-1.15; 95% CI: -2.00, -0.30; p=0.008). Risk factors including urinary uric acid excretion and pH were not significantly related to high water intake (SMD=7.32mg/d, 95% CI: -52.27, 66.91; p=0.81), (SMD=0.14; 95% CI: -0.02, 0.31; p=0.09), respectively. Further subgroup analyses revealed that urinary uric acid excretion was significantly decreased in healthy individuals (SMD=-36.23 mg/d, 95% CI: -65.14, -7.31; p=0.001) compared to stone formers (SMD=27.41 mg/d, 95% CI: -33.18, 88.01; p=0.38); urinary uric acid excretion was significantly decreased in routine water intake groups (SMD=-61.49 mg/d, 95% CI: -120.74, 12.24; p=0.04) compared to mineral water intake groups (SMD=44.50 mg/d, 95% CI: -18.30, 107.29; p=0.16); urinary pH was significantly higher in mineral water groups (SMD=0.13, 95% CI: 0.01, 0.46; p=0.04) compared to regular water groups (SMD=-0.00, 95% CI: -0.13, 0.13; p=0.98).

Results: A total of 129 patients had 150 internal jugular catheter insertions. The mean age was 51.4±15.2 years with male to female ratio of 1.5:1. All the patients had chronic kidney disease; about 80% had tunneled IJC and 96.9% of the catheters were inserted in the right internal jugular vein. Immediate complications were recorded in 10% and late complications in 34.9% of the procedures. The immediate complications were kinking of guide wire (2%), arterial puncture (1.3%) and difficulty in locating the internal jugular vein (1.3%) or tunneling (1.3%). The late complications were infection (12.8%), poor blood flow (9.2%), bleeding (5.5%) and spontaneous removal of the catheter (5.5%). There was no statistical significant difference in both immediate and late complication with age and sex.

Conclusion: This meta-analysis identified evidence that urinary uric acid excretion, volume, pH and relative supersaturation of uric acid can be altered with high water intake intervention, reducing the risk of uric acid kidney stones.

Read Full Article HTML DOI: 10.29328/journal.jcn.1001038 Cite this Article Read Full Article PDF

Keywords:

Meta-Analysis; High water intake; Uric Acid kidney stones; Risk factors

References

  1. Wiederkehr MR, Moe OW. Uric Acid Nephrolithiasis: A Systemic Metabolic Disorder. Clin Rev Bone Miner Metab. 2011; 9: 207-217. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25045326
  2. Ma Q, Fang L, Su R, Ma L, Xie G, et al. Uric acid stones, clinical manifestations and therapeutic considerations. Postgraduate Medical Journal. 2018; 94: 458-462. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30002092
  3. Abou-Elela A. Epidemiology, pathophysiology, and management of uric acid urolithiasis: A narrative review. Journal of Advanced Research. 2017; 8: 513-527. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28748117
  4. Moe OW. Kidney stones: pathophysiology and medical management. The Lancet. 2006; 367: 333-344. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16443041
  5. Sakhaee K. Epidemiology and clinical pathophysiology of uric acid kidney stones. Journal of Nephrology. 2014; 27: 241-245. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24497296
  6. Portis AJ, et al. High Prevalence of Gouty Arthritis among the Hmong Population in Minnesota. Arthritis Care & Research. 2010; 62: 1386-1391. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20506247
  7. Moe OW. Uric acid nephrolithiasis: proton titration of an essential molecule? Current Opinion in Nephrology and Hypertension, 2006; 15: 366-373. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16775450
  8. Xu C, Zhang C, Wang XL, Liu TZ, Zeng XT, et al. Self-Fluid Management in Prevention of Kidney Stones: A PRISMA-Compliant Systematic Review and Dose-Response Meta-Analysis of Observational Studies. Medicine. 2015; 94: 1042. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26166074
  9. Qaseem A, Dallas P, Forciea MA, Starkey M, Denberg TD, et al. Dietary and Pharmacologic Management to Prevent Recurrent Nephrolithiasis in Adults: A Clinical Practice Guideline from the American College of Physicians. Ann Intern Med. 2014; 161: 659-685. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25364887
  10. Wang CJ, Grantham JJ, Wetmore JB. The medicinal use of water in renal disease. Kidney Int. 2013; 84: 45-53. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23423255
  11. Bao YG, Wei Q. Water for preventing urinary stones. Cochrane Database of Systematic Reviews. 2012; 6.
  12. Borghi L, Meschi T, Amato F, Briganti A, Novarini A, et al. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. 1996; 155: 839-843. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/8583588
  13. Fink HA, Akornor JW, Garimella PS, MacDonald R, Cutting A, et al. Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials. Eur Urol. 2009; 56: 72-80. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19321253
  14. Pearle MS, et al. Medical management of kidney stones: AUA guideline. J Urol. 2014; 192: 316-324. PubMed:
  15. Fink HA, Goldfarb DS, Assimos DG, Curhan G, Denu-Ciocca CJ, et al. Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline. Ann Intern Med. 2013; 158: 535-543. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24857648
  16. Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Annals of Internal Medicine. 1997; 126: 497. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/9092314
  17. Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: New insights after 14 years of follow-up. J Am Soc Nephrol. 2004; 15: 3225-3232. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15579526
  18. Cheungpasitporn W, Rossetti S, Friend K, Erickson SB, Lieske JC. Treatment effect, adherence, and safety of high fluid intake for the prevention of incident and recurrent kidney stones: a systematic review and meta-analysis. Journal of Nephrology. 2016; 29: 211-219. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26022722
  19. Linder BJ, Rangel LJ, Krambeck AE. The effect of work location on urolithiasis in health care professionals. Urolithiasis. 2013; 41: 327-331. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23764693
  20. Sarica K, Inal Y, Erturhan S, Yağci F. The effect of calcium channel blockers on stone regrowth and recurrence after shock wave lithotripsy. Urological Research. 2006; 34: 184-189. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16463053
  21. Koletsi D, Fleming PS, Michelaki I, Pandis N. Heterogeneity in Cochrane and non-Cochrane meta-analyses in orthodontics. J Dent. 2018; 74: 90-94. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29738788
  22. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003; 327: 557-560. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12958120
  23. Da Costa BR, Nüesch E, Rutjes AW, Johnston BC, Reichenbach S, et al. Combining follow-up and change data is valid in meta-analyses of continuous outcomes: a meta-epidemiological study. J Clin Epidemiol. 2013; 66: 847-855. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23747228
  24. Thabane L, Mbuagbaw L, Zhang S, Samaan Z, Marcucci M, et al. A tutorial on sensitivity analyses in clinical trials: the what, why, when and how. BMC Med Res Methodol. 2013; 13: 92-92. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23855337
  25. Milewski JB, Krzeski T, Willak J. Effect of treatment with mineral water from the Dabrowka spring at the Szczawno-Zdroj health resort on uric acid levels of the blood and urine. Wiad Lek. 1987; 40: 875-878. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/3424837
  26. Neimark AI, Davydov AV. Use of "Serebrianyi Kliuch" mineral water in the postoperative treatment of patients with nephrolithiasis after extracorporeal shock-wave lithotripsy. Urologiia. 2003; 4: 44-46. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12942727
  27. Passman CM, Holmes RP, Knight J, Easter L, Pais V, et al. Effect of soda consumption on urinary stone risk parameters. J Endourol. 2009; 23: 347-350. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19275488
  28. Sweeney DD, Tomaszewski JJ, Ricchiuti DD, Averch TD. Effect of carbohydrate-electrolyte sports beverages on urinary stone risk factors. J Urol. 2009; 182: 992-997. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19616798
  29. Koff SG, Paquette EL, Cullen J, Gancarczyk KK, Tucciarone PR et al. Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation. Urology. 2007; 69: 1013-1016. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17572176
  30. Chen K, Chen D, Lan C, Liang X, Zeng T, et al. Does green tea consumption increase urinary oxalate excretion? Results of a prospective trial in healthy men. Int Urol Nephrol. 2018; 50: 29-33. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29052087
  31. Peng S. Clinical study of metabolic assessment in patients with renal calculi in diet prevention and treatment. International Medicine and Health Guidance News. 2018; 24: 2038-2042.
  32. Siener R, Jahnen A, Hesse A. Influence of a mineral water rich in calcium, magnesium and bicarbonate on urine composition and the risk of calcium oxalate crystallization. Eur J Clin Nutr. 2004; 58: 270-276. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/14749747
  33. Kessler T, Hesse A. Cross-over study of the influence of bicarbonate-rich mineral water on urinary composition in comparison with sodium potassium citrate in healthy male subjects. Br J Nutr. 2000; 84: 865-871. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11177203
  34. Mirzazadeh M, Nouran MG, Richards KA, Zare M, et al. Effects of drinking water quality on urinary parameters in men with and without urinary tract stones. Urology. 2012; 79: 501-507. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22173182
  35. Di Silverio F, D'Angelo AR. Prevention of renal calculosis: efficacy of Fiuggi water cure. Research Group on Renal Calculosis. Arch Ital Urol Androl. 1994; 66: 253-258. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/7812305
  36. Marangella M, Vitale C, Petrarulo M, Rovera L, Dutto F. Effects of mineral composition of drinking water on risk for stone formation and bone metabolism in idiopathic calcium nephrolithiasis. Clin Sci. 1996; 91: 313-318. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/8869414
  37. Iantorno R, Nicolai M, Ballone E, Passamonti M, Tenaglia R. Clinico-experimental study of low-mineral "Monteferrante" water: monitoring the recurrences in patients with calculi. Arch Ital Urol Androl. 1997; 69: 35-39. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/9181904
  38. Dzeranov NK, Beshliev DA, Golovanov SA, Kon'kova TA. Effects of mineral water TIB-2 on metabolic processes in urolithiasis patients. Urologiia. 2000; 3: 15-17. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11186701
  39. Konstantinova OV, Dutov VV, Katibov MI, Trapeznikova MF, Ianenko ÈK. Experience in the use of mineral water "Naftusya" of Zbruchansk field in the treatment of patients with uroliths. Urologiia. 2013; 6: 9-13. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24649756
  40. Noorwali AA. Tea Consumption as a Possible Risk Factor in Urolithiasis - a Preliminary-Report. Annals of Saudi Medicine. 1988; 8: 108-112.
  41. Alyami FA, Rabah DM. Effect of drinking parsley leaf tea on urinary composition and urinary stones' risk factors. Saudi J Kidney Dis Transpl. 2011; 22: 511-514. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21566309
  42. Rodgers AL. Effect of mineral water containing calcium and magnesium on calcium oxalate urolithiasis risk factors. Urol Int. 1997; 58: 93-99. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/9096270
  43. Popkin BM, D'Anci KE, Rosenberg IH. Water, hydration, and health. Nutrition reviews. 2010; 68: 439-458.
  44. Guelinckx I, Tavoularis G, König J, Morin C, Gharbi H, et al. Contribution of Water from Food and Fluids to Total Water Intake: Analysis of a French and UK Population Surveys. Nutrients. 2016; 8: 630. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27754402
  45. Nissensohn M, Sánchez-Villegas A, Galan P, Turrini A, Arnault N, et al. Beverage Consumption Habits among the European Population: Association with Total Water and Energy Intakes. Nutrients. 2017; 9. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28406441
  46. Lunny C, Brennan SE, McDonald S, McKenzie JE. Toward a comprehensive evidence map of overview of systematic review methods: paper 2-risk of bias assessment; synthesis, presentation and summary of the findings; and assessment of the certainty of the evidence. Systematic Reviews. 2018; 7: 159. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30314530
  47. Copas JB, Shi JQ. A sensitivity analysis for publication bias in systematic reviews. Stat Methods Med Res. 2001; 10: 251-265. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11491412
  48. Tipton E. Small sample adjustments for robust variance estimation with meta-regression. Psychol Methods. 2015; 20: 375-393. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24773356
  49. Pak CY, Sakhaee K, Peterson RD, Poindexter JR, Frawley WH. Biochemical profile of idiopathic uric acid nephrolithiasis. Kidney Int. 2001; 60: 757-761. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11473659
  50. Pak CYC, Poindexter JR, Peterson RD, Koska J, Sakhaee K. Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis. Urology. 2002; 60: 789-794. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12429297
  51. Martillo MA, Nazzal L, Crittenden DB. The crystallization of monosodium urate. Current rheumatology reports. 2014; 16: 400-400.
  52. Siener R. Can the manipulation of urinary pH by beverages assist with the prevention of stone recurrence? Urolithiasis. 2016; 44: 51-56. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26614113
  53. Kim S, Chang Y, Yun KE1, Jung HS, Lee SJ, et al. Development of Nephrolithiasis in Asymptomatic Hyperuricemia: A Cohort Study. Am J Kidney Dis. 2017; 70: 173-181. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28410765
  54. Ferrari P, Bonny O. Diagnosis and prevention of uric acid stones. Ther Umsch. 2004; 61: 571-574. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15493118
  55. Ngo TC, Assimos DG. Uric Acid nephrolithiasis: recent progress and future directions. Reviews in Urology. 2007; 9: 17-27. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17396168
  56. Trinchieri A. Diet and renal stone formation. Minerva Med. 2013; 104: 41-54.
  57. Meschi T, Nouvenne A, Borghi L. Lifestyle recommendations to reduce the risk of kidney stones. Urol Clin North Am. 2011; 38: 313-320. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21798393
  58. Prasad Sah OS, Qing YX, Associations between Hyperuricemia and Chronic Kidney Disease: A Review. Nephro-Urology Monthly. 2015; 7: e27233-e27233. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26290849
  59. Tang X, Lieske JC. Acute and chronic kidney injury in nephrolithiasis. Current opinion in nephrology and hypertension. 2014; 23: 385-390. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24848936
  60. Keddis MT, Rule AD. Nephrolithiasis and loss of kidney function. Current opinion in nephrology and hypertension. 2013; 22: 390-396.
  61. Cheungpasitporn W, Thongprayoon C, O'Corragain OA, Edmonds PJ, Ungprasert P, et al. The risk of kidney cancer in patients with kidney stones: a systematic review and meta-analysis. Qjm. 2015; 108: 205-212. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25208892
  62. Hess B. Metabolic syndrome, obesity and kidney stones. Arab journal of urology. 2012; 10: 258-264. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26558034
  63. Peng JP, Zheng H, Kidney stones may increase the risk of coronary heart disease and stroke: A PRISMA-Compliant meta-analysis. Medicine. 2017; 96: e7898-e7898. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28834909

Figures:

Figure 1

Figure 1

Figure 1

Figure 2

Figure 1

Figure 3

Figure 1

Figure 4

Figure 1

Figure 5

Figure 1

Figure 6

Figure 1

Figure 7

Figure 1

Figure 8

Figure 1

Figure 9

Figure 1

Figure 10

Figure 1

Figure 11

Figure 1

Figure 12

Figure 1

Figure 13

Figure 1

Figure 14

Figure 1

Figure 15

Figure 1

Figure 16

Figure 1

Figure 17

Figure 1

Figure 18

Figure 1

Figure 19

Figure 1

Figure 20

Figure 1

Figure 21

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?